Skip to content Skip to footer
IR 投資家情報
  • 日本語
  • Americas
NAGASE
Search
Industries
Industries Overview
INDUSTRIES
Chemicals Coatings & Inks Printing & Packaging Polymers & Resins Electronics Energy Automotive & Transportation Food & Nutrition Agriculture & Animal Nutrition Personal Care Healthcare & Pharmaceuticals Building & Construction
Products
View All
PRODUCTS BY INDUSTRY
Chemicals Coatings & Inks Polymers & Resins Electronics Energy Automotive & Transportation Food & Nutrition Personal Care Healthcare & Pharmaceuticals
Services
Services Overview
Formulation
Product Development
Manufacturing
Supply Chain
Distribution and Logistics
Regulatory Compliance
Products
FEATURED CONTENT
Eastman Tritan clear copolyester tableware assortment

Eastman Tritan™ Copolyester

Solving for Hazardous Material Disposal

Integrated Resin and Metal Molding Design for EV Motor Parts

Innovation
Innovation Overview
INNOVATION FACILITIES
Nagase Application Workshop Nagase Bio-Innovation Center Nagase Biotech Office Future Co-creation Office EMPOWR3D
FEATURED RESOURCES
Close-up view of 3D printing complicated plastic part from blue filament. Producing of 3D object from digital model using additive manufacturing.

Creating Specialty Alignment Tools

Innovative Peptide-Oligo Conjugate Manufacturing Solutions

Sustainability
Sustainability Overview
FEATURED CONTENT
 TiMELESS @ WOC Brussels 2026

TiMELESS at WOC Brussels 2026

Jeans. Stylish clothes. Selective focus Shopping time Nature

Transforming the Dye Industry for a Sustainable Future

Creating Clean Beauty Products with Upcycled Materials

Company
Company Overview
Global Network
Group Companies
History
GLOBAL NETWORK
Japan China/Taiwan South Korea ASEAN, Middle East and Oceania India North America, Central America, and South America Europe
FEATURED CONTENT

Nagase Vietnam’s Digital Transformation Journey

Unlock the Japan Market with NAGASE

Discover
News & Events
Case Studies
Webinars
Whitepapers
View All Resources
FEATURED RESOURCES
Data Center Infrastructure & Cooling Solutions

Data Center Infrastructure & Cooling Solutions

TiMELESS at WoC Brussels 2026

TiMELESS at WoC Brussels 2026

Xenomax: Transforming Aerospace Solar Power

  • Industries
    Industries Overview
    INDUSTRIES
    Chemicals Coatings & Inks Printing & Packaging Polymers & Resins Electronics Energy Automotive & Transportation Food & Nutrition Agriculture & Animal Nutrition Personal Care Healthcare & Pharmaceuticals Building & Construction
  • Products
    View All
    PRODUCTS BY INDUSTRY
    Chemicals Coatings & Inks Polymers & Resins Electronics Energy Automotive & Transportation Food & Nutrition Personal Care Healthcare & Pharmaceuticals
  • Services
    Services Overview
    Formulation
    Product Development
    Manufacturing
    Supply Chain
    Distribution and Logistics
    Regulatory Compliance
    Products
    FEATURED CONTENT
    Eastman Tritan clear copolyester tableware assortment

    Eastman Tritan™ Copolyester

    Solving for Hazardous Material Disposal

    Integrated Resin and Metal Molding Design for EV Motor Parts

  • Innovation
    Innovation Overview
    INNOVATION FACILITIES
    Nagase Application Workshop Nagase Bio-Innovation Center Nagase Biotech Office Future Co-creation Office EMPOWR3D
    FEATURED RESOURCES
    Close-up view of 3D printing complicated plastic part from blue filament. Producing of 3D object from digital model using additive manufacturing.

    Creating Specialty Alignment Tools

    Innovative Peptide-Oligo Conjugate Manufacturing Solutions

  • Sustainability
    Sustainability Overview
    FEATURED CONTENT
     TiMELESS @ WOC Brussels 2026

    TiMELESS at WOC Brussels 2026

    Jeans. Stylish clothes. Selective focus Shopping time Nature

    Transforming the Dye Industry for a Sustainable Future

    Creating Clean Beauty Products with Upcycled Materials

  • Company
    Company Overview
    Global Network
    Group Companies
    History
    GLOBAL NETWORK
    Japan China/Taiwan South Korea ASEAN, Middle East and Oceania India North America, Central America, and South America Europe
    FEATURED CONTENT

    Nagase Vietnam’s Digital Transformation Journey

    Unlock the Japan Market with NAGASE

  • Discover
    News & Events
    Case Studies
    Webinars
    Whitepapers
    View All Resources
    FEATURED RESOURCES
    Data Center Infrastructure & Cooling Solutions

    Data Center Infrastructure & Cooling Solutions

    TiMELESS at WoC Brussels 2026

    TiMELESS at WoC Brussels 2026

    Xenomax: Transforming Aerospace Solar Power

  • Investor Relations (IR)
Contact Us
  • 日本語
  • Americas
  • 日本語
  • Americas
  1. Home
  2. Products
  3. Monoclonal Antibodies

Monoclonal Antibodies

A comprehensive portfolio of high-purity, clinical-grade monoclonal antibodies (mAbs) designed for in vitro diagnostic (IVD) assay development. Developed via hybridoma technology and recombinant expression systems, these antibodies are validated across diagnostic platforms to ensure consistent performance, clinical correlation, and batch-to-batch consistency. Optimized for diverse immunoassays, they cover diagnostic panels including cardiac markers, infectious diseases, tumor markers, and inflammatory diseases.

High-Performance Antibody & Antigen Portfolios for IVD Assays | Whitepaper
Request a Quote

Applications & Uses:

  • Chemiluminescent immunoassays (CLIA) and ELISA
  • Lateral flow assays (rapid tests) using colloidal gold or fluorescent nanoparticles
  • Latex particle-enhanced immunoturbidimetric assays (PETIA)
  • Active capture and detection pairs in sandwich immunoassay systems

Diagnostic Target Panels (mAbs):

  • Cardiac Markers: Troponin I, Troponin T, NT-proBNP, D-Dimer, Myoglobin, CK-MB
  • Infectious Diseases: Influenza A/B, RSV, Adenovirus, Strep A, Malaria, Dengue
  • Tumor Markers: AFP, CEA, PSA (Free and Total), PIVKA-II, CA125, CA19-9
  • Inflammatory Markers: CRP, Procalcitonin (PCT), SAA, IL-6

Benefits:

  • High lot-to-lot consistency: Large-scale production capacity ensuring consistent batch performance with a coefficient of variation (CV) of less than 5%.
  • Proven clinical correlation: Validated against industry-standard commercial assays (e.g., troponin T correlation R-squared of 0.98 or higher; D-Dimer correlation R-squared of 0.98 or higher).
  • High specificity and sensitivity: Selected matched pairs ensure minimal matrix interference and high dilution linearity without hook effects at standard clinical ranges.

Performance Attributes:

  • Exhibit high affinity with an affinity constant Ka of 1 billion to 10 billion M-1 or higher.
  • Provide highly specific matched antibody pairs for sandwich immunoassay.
  • Ensure reliable sensitivity and low cross-reactivity across targeted clinical panels.
Infectious Diseases Tumor Markers Inflammation Thyroid Autoimmune
HIV I CA153 CRP T3 Jo-1
HIV II CA154 PCT T4 CENP-B
HIV P24 CA155 IL-6 TSH SS-B/La
HIV-O Pro-GRP SAA TPO Ab Ro52
HCV CY211 Hormones TG SS-A/Ro60
TP CY242 AMH FT4 Scl-70
HBSAg CA724 INH-B Drug Abuse PM-ScI
HBe-Ab/Ag SCCA Testo MDMA Sm
HBSAb PGI Prog PCP U1 snRNP A
HBV-Pres1/2 PGII E2 BAR U1 snRNP C
RV CA125 FSH ETG PR3
HSV-I CA199 PRL AMP LA-2
HSV-II HE4 LH BZO B2-GP1
HAV CA50 HCG COC SLO
HEV AFP Bone Metabolic MET SLA/LP
HTLV CEA 25-OH Vitamin D BUP LC-1
EBV PSA PTH MTD gp210
ROT PIVKA II Hypertension THC GBM
NV S100 ALD Rheumatism PCNA
Respiratory Disease FIT Cortisol ASO Ku70/80
Flu A NSE Renin RF Histones
Flu B Cardiac Marker Diabetes CCP Nucleosome
Cov19 NT-proBNP GAD65 Kidney dsDNA
RSV CK-MB IA2 CysC SnRNP70
Strep A cTnI Insulin β2M ANA
MP (Mycoplasma Pneumoniae) MYO C-peptide RBP Dsg1
Adv ST2 HbA1c mALB Dsg3
HMPV BNP ADPN A1M BP180
Tropical Disease SA Digestion&Metabolism Apolipoproteins BP230
MA-HRPII-Pf H-FABP HP ApoA1 RPLP0
MA-PLDH-PV Lp-PLA2 FOB ApoB C1q-IgG
MA-PLDH-PAN Immunoglobulin & Complement PA Lp(a) C2q-IgG
MA-PLDH-PF IgA Anemia Coagulation tTG
Dengue E IgM TRF FDP sp100
Anti-NS1 IgG Ferritin D-Dime AMA-M2
Salmonella Typhosa Complement C3 Reproduction&Pregnancy IF
Complement C4 TOXO Alzheimer's Diseases
IgE CMV pTau-217
Kappa pTau-181
Lambda Aβ42
Aβ40
APOE 4
GFAP
Allergy
F2
F14
F4
w1

Sub Category:

Antibodies/Antigens

Industries:

  • Healthcare & Pharmaceuticals

Categories:

  • In-Vitro Diagnostics Materials

Country of origin:

  • JP, CN

Physical Properties:

Appearance: Clear, colorless to slightly yellow liquid
Solubility: Fully miscible in aqueous buffers
Molecular Weight: Approximately 150,000 Daltons (IgG)

Chemical Properties:

Purity: Equal to or greater than 95% by SDS-PAGE
Buffer formulation: Supplied in standard PBS (pH 7.2 to 7.4), available as azide-free or with 0.1% sodium azide depending on the grade

We’re Here to Help

Complete the following fields with your information, as well as a short, detailed description of your request and a NAGASE Specialist will be in touch with you shortly.

About Nagase
Company Overview Company Profile History Global Network Group Companies Investor Relations News Media Request
Products & Services
Products Industries Services Innovation Sustainability Resources
Site Information
Terms of Use Privacy Global Privacy Policy Cookie Policy Social Media Policy Trademarks Site Map
Get In Touch
Learn more about our products and services or to request a quote.
Contact Us

© {{lastPublishedYear}} Nagase & Co., Ltd. All rights reserved.

Get In Touch
Learn more about our products and services or to request a quote.
Contact Us
About Nagase
Company Overview Company Profile History Global Network Group Companies Investor Relations News Media Request
Products & Services
Products Industries Services Innovation Sustainability Resources
Site Information
Terms of Use Privacy Global Privacy Policy Cookie Policy Social Media Policy Trademarks Site Map

© {{lastPublishedYear}} Nagase & Co., Ltd. All rights reserved.